Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001088274 | SCV000285608 | benign | Brugada syndrome | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000245353 | SCV000318606 | likely benign | Cardiovascular phenotype | 2016-02-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000710355 | SCV000534042 | likely benign | not provided | 2021-04-07 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000710355 | SCV000840558 | benign | not provided | 2017-10-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000710355 | SCV004162360 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | CACNA2D1: BP4, BP7, BS2 |
Clinical Genetics, |
RCV000427711 | SCV001920029 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000710355 | SCV001928829 | likely benign | not provided | no assertion criteria provided | clinical testing |